Panacea Life Sciences Limited, a active public limited company, was established on 20 May 2016 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74995DL2016PLC300077. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Ganesh Kumraj (Director), Shilpy Jain (Director), Nipun Jain (Director). Past directors included Ganesh Kumraj, Shilpy Jain, Indra Kumar Sharma. Its latest AGM occurred on 09 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-43, 1St Floor Nizamuddin East,, New Delhi, Delhi, 110013.
U74995DL2016PLC300077
300077
20 May 2016
₹6.00 M
₹2.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Panacea Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Kumraj | Director | 10 Mar 2022 | Current |
| Shilpy Jain | Director | 26 Feb 2021 | Current |
| Nipun Jain | Director | 08 Aug 2022 | Current |
| Pradip Jain | Director | 20 May 2016 | Current |
| Sumit Jain | Director | 04 Jul 2016 | Current |
| Sunanda Jain | Director | 27 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 26 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Panacea Life Sciences Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.92% decrease. The company also saw a substantial improvement in profitability, with a 56.86% increase in profit. The company's net worth dipped by a decrease of 3.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Panacea Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Panacea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Panacea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Panacea Life Sciences Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records. was recorded as a recent event.
Panacea Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Nipun Jain was appointed as a Director was appointed as a Director on 08 Aug 2022 & has been associated with this company since 3 years 4 months . was documented.
Ganesh Kumraj was appointed as a Director was appointed as a Director on 10 Mar 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.
The activity Sunanda Jain was appointed as a Director was appointed as a Director on 27 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
The activity Shilpy Jain was appointed as a Director was appointed as a Director on 26 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
The CIN of Panacea Life Sciences Limited is U74995DL2016PLC300077.
Panacea Life Sciences Limited is headquartered at C-43, 1St Floor Nizamuddin East,, New Delhi, Delhi, 110013.
Panacea Life Sciences Limited was incorporated on 20 May 2016.
The current directors of Panacea Life Sciences Limited are
The primary industry of Panacea Life Sciences Limited is Manufacturing.
Panacea Life Sciences Limited is unlisted.
The authorized capital of Panacea Life Sciences Limited is ₹6.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Panacea Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX